These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35979719)

  • 1.
    Van Trimpont M; Schalk AM; De Visser Y; Nguyen HA; Reunes L; Vandemeulebroecke K; Peeters E; Su Y; Lee H; Lorenzi PL; Chan WK; Mondelaers V; De Moerloose B; Lammens T; Goossens S; Van Vlierberghe P; Lavie A
    Haematologica; 2023 Feb; 108(2):409-419. PubMed ID: 35979719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
    Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
    Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias
    Nguyen HA; Su Y; Zhang JY; Antanasijevic A; Caffrey M; Schalk AM; Liu L; Rondelli D; Oh A; Mahmud DL; Bosland MC; Kajdacsy-Balla A; Peirs S; Lammens T; Mondelaers V; De Moerloose B; Goossens S; Schlicht MJ; Kabirov KK; Lyubimov AV; Merrill BJ; Saunthararajah Y; Van Vlierberghe P; Lavie A
    Cancer Res; 2018 Mar; 78(6):1549-1560. PubMed ID: 29343523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.
    Chan WK; Lorenzi PL; Anishkin A; Purwaha P; Rogers DM; Sukharev S; Rempe SB; Weinstein JN
    Blood; 2014 Jun; 123(23):3596-606. PubMed ID: 24659632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and Characterization of Erwinia Chrysanthemi l-Asparaginase Variants with Diminished l-Glutaminase Activity.
    Nguyen HA; Su Y; Lavie A
    J Biol Chem; 2016 Aug; 291(34):17664-76. PubMed ID: 27354283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico engineering of L-asparaginase to have reduced glutaminase side activity for effective treatment of acute lymphoblastic leukemia.
    Ln R; Doble M; Rekha VP; Pulicherla KK
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):617-21. PubMed ID: 22042278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-asparaginase-mediated Therapy in L-asparagine Auxotrophic Cancers: A Review.
    Sindhu R; Manonmani HK
    Anticancer Agents Med Chem; 2022; 22(13):2393-2410. PubMed ID: 34994334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial l-asparaginases for cancer therapy: Current knowledge and future perspectives.
    Ghasemian A; Al-Marzoqi AH; Al-Abodi HR; Alghanimi YK; Kadhum SA; Shokouhi Mostafavi SK; Fattahi A
    J Cell Physiol; 2019 Nov; 234(11):19271-19279. PubMed ID: 30993718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-Asparaginase delivery systems targeted to minimize its side-effects.
    Talluri VP; Mutaliyeva B; Sharipova A; Ulaganathan V; Lanka SS; Aidarova S; Suigenbayeva A; Tleuova A
    Adv Colloid Interface Sci; 2023 Jun; 316():102915. PubMed ID: 37159987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of L-asparaginase in childhood ALL.
    Müller HJ; Boos J
    Crit Rev Oncol Hematol; 1998 Aug; 28(2):97-113. PubMed ID: 9768345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-asparaginase anti-tumor activity in pancreatic cancer is dependent on its glutaminase activity and resistance is mediated by glutamine synthetase.
    Blachier J; Cleret A; Guerin N; Gil C; Fanjat JM; Tavernier F; Vidault L; Gallix F; Rama N; Rossignol R; Piedrahita D; Andrivon A; Châlons-Cottavoz M; Aguera K; Gay F; Horand F; Laperrousaz B
    Exp Cell Res; 2023 May; 426(2):113568. PubMed ID: 36967104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circumventing the side effects of L-asparaginase.
    Fonseca MHG; Fiúza TDS; Morais SB; Souza TACB; Trevizani R
    Biomed Pharmacother; 2021 Jul; 139():111616. PubMed ID: 33932739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
    Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
    Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the Treatment of Acute Lymphoblastic Leukemia.
    Radadiya A; Zhu W; Coricello A; Alcaro S; Richards NGJ
    Biochemistry; 2020 Sep; 59(35):3193-3200. PubMed ID: 32786406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.
    Parmentier JH; Maggi M; Tarasco E; Scotti C; Avramis VI; Mittelman SD
    Leuk Res; 2015 Jul; 39(7):757-62. PubMed ID: 25941002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.
    Emadi A; Law JY; Strovel ET; Lapidus RG; Jeng LJB; Lee M; Blitzer MG; Carter-Cooper BA; Sewell D; Van Der Merwe I; Philip S; Imran M; Yu SL; Li H; Amrein PC; Duong VH; Sausville EA; Baer MR; Fathi AT; Singh Z; Bentzen SM
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):217-222. PubMed ID: 29119293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.
    Nguyen HA; Durden DL; Lavie A
    Sci Rep; 2017 Jan; 7():41643. PubMed ID: 28139703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asparaginase in the treatment of non-ALL hematologic malignancies.
    Emadi A; Zokaee H; Sausville EA
    Cancer Chemother Pharmacol; 2014 May; 73(5):875-83. PubMed ID: 24515335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a bioengineered Erwinia chrysanthemi asparaginase to enhance its anti-solid tumor potential for treating gastric cancer.
    Tam SY; Chung SF; Kim CF; To JC; So PK; Cheung KK; Chung WH; Wong KY; Leung YC
    Int J Biol Macromol; 2023 Dec; 253(Pt 5):127742. PubMed ID: 37923039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clinical and subclinical hypersensitivity to asparaginase in acute lymphoblastic leukemia.
    Asselin BL; Fisher V
    Clin J Oncol Nurs; 2014 Dec; 18(6):E107-12. PubMed ID: 25427712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.